Skip to main content
Premium Trial:

Request an Annual Quote

NSF Awards Cyntellect $500K SBIR to Develop LaserFect for RNAi Applications

NEW YORK, June 27 (GenomeWeb News) - Cyntellect will receive approximately $500,000 from the National Science Foundation to continue developing its LEAP (laser-enabled analysis and processing) transfection system for RNAi applications, the company said today.


The company said it will use the Phase IIB Small Business Innovative Research grant to enable "high-efficiency, low-toxicity delivery of siRNA into cells that are typically refractory to standard transfection techniques."


NSF's Phase IIB SBIR program provides matching funds up to $500,000 to companies that meet the goals of a Phase II grant and are also able to secure additional investment from non-governmental sources.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.